Sysmex Inostics
supplies PlasmaSeqSensei NGS kits and targeted panel assays for oncology, with published clinical evidence (JAMA Oncology) that its circulating-tumor-HPV-DNA (HPV-Seq) assay predicts improved survival when used to monitor treatment clearance.
- Country
- Germany
Commercial
PlasmaSeqSensei NGS kits
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Liquid biopsy & ctDNA diagnostics | diagnostics-medtech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.